Inventor · disambiguated record
Rudolf Lucas
Also filed as: LUCAS RUDOLF
12 granted patents·10 pending applications·8 citations·filing 2001–2025
82Inventor score
Files withAPEPTICO FORSCHUNG & ENTWICKLUNG GMBH12FISCHER BERNHARD5LUCAS RUDOLF DR1RENTSCHLER BETEILIGUNGS GMBH1UNIV MIAMI1
Top patents by PatentIndex Score
22 records- 0169US8501679B2Cyclic, cystein-free proteinFISCHER BERNHARD·Filed 2008·Granted Aug 6, 2013·1 cites·9 claims
- 0267US11639368B2Method for preventing and treating hyperpermeabilityAPEPTICO FORSCHUNG & ENTWICKLUNG GMBH·Filed 2018·Granted May 2, 2023·0 cites·14 claims
- 0363US7258861B2TNF-derived peptides for use in treating oedemaLUCAS RUDOLF DR·Filed 2002·Granted Aug 21, 2007·7 cites·26 claims
- 0458US8372799B2Reverse proteinAPEPTICO FORSCHUNG & ENTWICKLUNG GMBH·Filed 2008·Granted Feb 12, 2013·0 cites·14 claims
- 0558US2025222065A1Cyclic polypeptide for the treatment of pha type 1bAPEPTICO FORSCHUNG & ENTWICKLUNG GMBH·Filed 2025·Application pending·0 cites
- 0656US2024181015A1Effect of ghrh antagonists in diabetes and obesityUNIV RES INST INC AUGUSTA·Filed 2022·Application pending·0 cites
- 0755US11161881B2Composition comprising a peptide and an inhibitor of viral neuraminidaseAPEPTICO FORSCHUNG & ENTWICKLUNG GMBH·Filed 2020·Granted Nov 2, 2021·0 cites·20 claims
- 0855US2014364358A1Method for Preventing and Treating HyperpermeabilityAPEPTICO FORSCHUNG & ENTWICKLUNG GMBH·Filed 2014·Application pending·0 cites
- 0952US10711041B2Lyophilisate containing a cyclic peptide of formula X1-GQRETPEGAEAKPWY-X2APEPTICO FORSCHUNG & ENTWICKLUNG GMBH·Filed 2014·Granted Jul 14, 2020·0 cites·11 claims
- 1052US9802985B2Pharmaceutical composition for treatment of the pulmonary form of altitude sickness caused by lack of oxygen and reduced air pressureAPEPTICO FORSCHUNG & ENTWICKLUNG GMBH·Filed 2013·Granted Oct 31, 2017·0 cites·10 claims
- 1151US12004506B2Pharmaceutical composition comprising a cyclic peptide of formula X1-GQRETPEGAEAKPWY-X2 and use for extracorporeal lung treatmentAPEPTICO FORSCHUNG & ENTWICKLUNG GMBH·Filed 2020·Granted Jun 11, 2024·0 cites·15 claims
- 1250US10201588B2Materials and methods of treating dyslipidemiaUNIV MIAMI·Filed 2017·Granted Feb 12, 2019·0 cites·7 claims
- 1348US10344055B2Composition comprising a peptide and an inhibitor of viral neuraminidaseFISCHER BERNHARD·Filed 2011·Granted Jul 9, 2019·0 cites·15 claims
- 1448US2019309021A1Composition Comprising a Peptide and an Inhibitor of Viral NeuraminidaseAPEPTICO FORSCHUNG & ENTWICKLUNG GMBH·Filed 2019·Application pending·0 cites
- 1545US2011319316A1Method for Preventing and Treating HyperpermeabilityFISCHER BERNHARD·Filed 2010·Application pending·0 cites
- 1644US2019211061A1Pharmaceutical composition for treatment of the pulmonary form of altitude sickness caused by lack of oxygen and reduced air pressureAPEPTICO FORSCHUNG & ENTWICKLUNG GMBH·Filed 2017·Application pending·0 cites
- 1739US2019351010A1Cyclic polypeptide for the treatment of pha type 1bAPEPTICO FORSCHUNG & ENTWICKLUNG GMBH·Filed 2016·Application pending·0 cites
- 1838US2016143266A1Pharmaceutical Composition Comprising a Cyclic peptide of formula X1-GQRETPEGAEAKPWY-X2 and use for extracorporeal lung treatmentAPEPTICO FORSCHUNG & ENTWICKLUNG GMBH·Filed 2014·Application pending·0 cites
- 1938US2010317565A1Novel Peptides and Their Use for the Treatment of EdemaRENTSCHLER BETEILIGUNGS GMBH·Filed 2008·Application pending·0 cites
- 2037US9359419B2Treatment of vascular complications of diabetesFISCHER BERNHARD·Filed 2010·Granted Jun 7, 2016·0 cites·11 claims
- 2134US2003105021A1TNF-derived peptides for use in treating oedemaFiled 2001·Application pending·0 cites
- 2232US8754049B2Organic compound for the regulation of vectorial ion channelsFISCHER BERNHARD·Filed 2011·Granted Jun 17, 2014·0 cites·9 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →